OpenFieldKobe Pharmaceutical University (Kobeyakka) is one of Japan’s oldest and most prestigious private pharmaceutical universities, founded in 1932 in Kobe and celebrated for medicinal chemistry, pharmacogenomics, natural drug discovery, and clinical hospital pharmacy.
Established in 1932 as the Kobe Women's College of Pharmacy and reorganized in 1994 as a coeducational pharmaceutical university, Kobeyakka has educated generations of Japan’s leading clinical pharmacists, pharmacological researchers, and drug discovery scientists. Situated on the scenic heights of Mount Rokko in Higashinada-ku, Kobe, the university features advanced laboratories for nuclear magnetic resonance (NMR), mass spectrometry, a medicinal botanical garden with over 1,200 medicinal plant species, and intimate research alliances with Kobe University Hospital and the RIKEN Center for Biosystems Dynamics Research.
Three-to-four year doctoral fellowship providing full tuition remission and research funding for scholars synthesizing novel heterocyclic bioactive molecules.
Merit scholarship awarded to top-ranking students in the six-year pharmaceutical clinical program to reward outstanding academic achievement.
Two-year graduate degree utilizing Kobeyakka's medicinal botanical garden and high-field NMR to isolate bioactive secondary metabolites from medicinal herbs.
Professional six-year clinical pharmacy curriculum combining advanced pharmacokinetics, drug toxicology, and mandatory clinical hospital rotations.
Twenty-two week mandatory hospital clinical training embedded inside university medical centers managing chemotherapy regimens and therapeutic drug monitoring.
Six-week summer research placement investigating antimicrobial and antioxidant metabolites from rare botanical specimens in the Kobeyakka botanical collection.
Four-month evening certification program for licensed hospital pharmacists on CYP450 polymorphism testing, HLA-B genetic screening, and targeted kinase inhibitors.
Professor of Synthetic Organic Chemistry and Drug Discovery
Synthetic organic chemist developing novel chiral organocatalysts for the enantioselective total synthesis of complex marine alkaloids and anticancer natural products.
Topics: Asymmetric Catalysis, Synthesis of Bioactive Alkaloids, Organocatalytic Cascade Reactions
View researcher profile ↗Professor of Pharmaceutics and Biopharmaceutics
Biopharmaceutics researcher investigating solute carrier (SLC) transporters at the blood-brain barrier and placenta to design drugs that penetrate the central nervous system.
Topics: Blood-Brain Barrier Transport, Placental Drug Permeation, Membrane Transporter Kinetics
View researcher profile ↗Professor of Pharmacology and Neurobiology
Pharmacologist analyzing microvascular disease in stroke and vascular cognitive impairment, evaluating novel receptor antagonists that restore cerebral perfusion.
Topics: Endothelial Dysfunction, Vascular Dementia Mechanisms, Cerebrovascular Pharmacology
View researcher profile ↗All listings are compiled from official university sources and reviewed under OpenField editorial standards. Program availability, scholarship quotas, and entry requirements are subject to university revisions. Applicants should confirm all deadlines with Kobe Pharmaceutical University (Kobeyakka)'s official admissions office.
Reviewed 2026-10-15 · Editorial standards · Report an issue